All In Biotech

Drug Trial Radar · NCT05362058

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes

Last checked: Nov 20, 2026Latest source record: May 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 928 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

928

Actual

Start

Jun 3, 2022

Primary completion

Apr 10, 2024

Study completion Apr 10, 2024

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 5, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the effect and safety of insulin efsitora alfa (LY3209590) compared to degludec in adult participants with type 2 diabetes who are starting basal insulin for the first time. The study consists of a 1-week screening period, a 2-week lead-in period, a 52-week treatment period, and a 5-week safety follow-up period. The study will last up to 60 weeks.

Conditions

  • Diabetes
  • Type 2 Diabetes

Interventions

  • Insulin Efsitora AlfaDrug

    Administered SC

  • Insulin DegludecDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in HbA1c at Week 52 [Noninferiority Analysis]Time frame: Baseline, Week 52

Locations

113 sites in 11 countries. Site status is shown where the registry gives one.

  • Neighborhood Healthcare Institute of Health

    Escondido, California

  • Valley Research

    Fresno, California

  • NorCal Medical Research, Inc

    Greenbrae, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Southern California Dermatology, Inc.

    Santa Ana, California

  • New West Physicians Clinical Research

    Golden, Colorado

  • New England Research Associates, LLC

    Bridgeport, Connecticut

  • East Coast Institute for Research, LLC

    Jacksonville, Florida

  • East Coast Institute for Research - Canton

    Canton, Georgia

  • Rophe Adult and Pediatric Medicine/SKYCRNG

    Union City, Georgia

  • Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative

    Springfield, Illinois

  • Qualmedica Research, LLC

    Evansville, Indiana

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa

  • Qualmedica Research

    Bowling Green, Kentucky

  • MedStar Health Research Institute (MedStar Physician Based Research Network)

    Hyattsville, Maryland

  • Endocrine and Metabolic Consultants

    Rockville, Maryland

  • SKY Clinical Research Network Group-Quinn

    Ridgeland, Mississippi

  • Clinvest Research LLC

    Springfield, Missouri

  • Clarity Clinical Research

    East Syracuse, New York

  • Great Lakes Medical Research, LLC

    Westfield, New York

  • Monroe Biomedical Research

    Monroe, North Carolina

  • Lucas Research, Inc

    Morehead City, North Carolina

  • Intend Research, LLC

    Norman, Oklahoma

  • Jefferson Clinical Research Institute (JCRI)

    Philadelphia, Pennsylvania

  • Tribe Clinical Research, LLC

    Greenville, South Carolina

  • Dallas Diabetes Research Center

    Dallas, Texas

  • Juno Research

    Houston, Texas

  • Southern Endocrinology Associates

    Mesquite, Texas

  • North Hills Family Medicine/North Hills Medical Research

    North Richland Hills, Texas

  • Multicare Institute for Research and Innovation

    Spokane, Washington

  • Hospital São Lucas de Copacabana

    Rio de Janeiro, Brazil

  • CPQuali Pesquisa Clínica

    São Paulo, Brazil

  • CPCLIN

    São Paulo, Brazil

  • CEPIC - Centro Paulista de Investigação Clínica

    São Paulo, Brazil

  • CEDOES

    Vitória, Espírito Santo, Brazil

  • Cline Research Center

    Curitiba, Paraná, Brazil

  • Centro de Pesquisa Sao Lucas

    Campinas, São Paulo, Brazil

  • LMC Diabetes & Endocrinology

    Brampton, Ontario, Canada

  • Aggarwal and Associates Limited

    Brampton, Ontario, Canada

  • LMC Manna Research

    Ottawa, Ontario, Canada

Showing 40 of 113 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.